News und Analysen
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics Plc
5 Smart Reasons to Buy AT&T Stock Right Now
Shares of AT&T (NYSE: T) are trading near multi-decade lows. Bargain hunters are circling and for good reason. Many of the risks the telecom titan faces are arguably already reflected in its
Looking for the Next Big Biopharma Stock? These 4 Letters Are 1 Big Clue Where to Find It
If you've invested in biopharma anytime recently, you've probably heard the acronym NASH. It stands for nonalcoholic steatohepatitis, a liver disease characterized by fat accumulating on the liver
Why Medtronic Stock Was a Winner Today
Tuesday was a fine day to be a Medtronic (NYSE: MDT) investor. The company's performance in its inaugural quarter of fiscal 2024 was better than expected, and the market rewarded Medtronic shares
Medtronic (MDT) Q1 2024 Earnings Call Transcript
Medtronic (NYSE: MDT)Q1 2024 Earnings CallAug 22, 2023, 8:00 a.m. ET
Ryan Weispfenning
Source Fool.com
Why Are Shares of Novavax Soaring Today?
Investors in Novavax (NASDAQ: NVAX) haven't had much to celebrate recently, but the stock is rocketing higher on Tuesday. As of 11:30 a.m. ET, Novavax shares were up more than 17%, despite the
3 Revolutionary Stocks I'd Buy Right Now Without Hesitation
The healthcare sector is a hotbed of innovation, and those companies that genuinely break new ground are often handsomely rewarded, along with their shareholders. Investors looking to earn outsized
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics Plc
2 Reasons to Buy AT&T Stock, and 1 Reason to Avoid It
Every investor has different timelines and goals, and the stocks they select to fill a portfolio should mirror those goals. While some may not care about dividends, others value them highly, even if
EQS-News: Evotec SE reports first half-year 2023 results on 29 August 2023
Is AT&T's Massive Debt Threatening Its Dividend?
Fool.com contributor Parkev Tatevosian reviews AT&T's (NYSE: T) long-term debt regarding its ability to pay dividends.
*Stock prices used were the afternoon prices of Aug. 19, 2023. The video was
What's Going on With AT&T Stock?
Fool.com contributor Parkev Tatevosian provides insights into AT&T's (NYSE: T) near-term prospects.
*Stock prices used were the afternoon prices of Aug. 18, 2023. The video was published on Aug
Wall Street Thinks Illumina Stock Will Rise 27% in 1 Year. Here's Why That Probably Won't Happen.
Wall Street analysts are upbeat on California-based biotech Illumina (NASDAQ: ILMN) these days, estimating on average that the stock could climb by up to 27% over the next year. But without some
Is Amgen Stock a Top Buy and Hold?
Buying individual stocks can be a smart way to build wealth over time. However, the reality of the situation is that it's exceptionally difficult to consistently beat the market averages over time
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics Plc
Is Regeneron Pharmaceuticals Still a Top Growth Stock?
Regeneron Pharmaceuticals (NASDAQ: REGN) is a leader in the field of therapeutic proteins, with a history of more than 30 years of innovation and excellence. The biotech has partnered with Bayer to
3 Fantastic Stocks to Buy in a New Bull Market
A new bull market is here ... almost. Some maintain that the S&P 500 has already begun a new bull market. Others, though, argue that the index must reach an all-time high first. Either way, many
Looking for Passive Income? This Dividend Stock Has You Covered.
Investors have enjoyed some generous returns so far in 2023, with the S&P 500 up 17% and the tech-heavy Nasdaq up 31% as of this writing. Given these returns, investor expectations have been
2 Healthcare Stocks You Can Buy and Hold for the Next Decade
Over the past few years, several hot investing trends swept through Wall Street. First, it was the metaverse, and now it's artificial intelligence; there will likely be some new big thing in a year
3 Under-the-Radar Biotech Stocks to Buy in 2023
Most people have either had cancer themselves or know someone who has. According to the American Cancer Society, 1 in 3 people in the U.S. will be diagnosed with one of the numerous forms of cancer.
Best Dividend Stocks to Buy: AT&T Stock vs. Altria Stock
Fool.com contributor Parkev Tatevosian compares AT&T (NYSE: T) and Altria (NYSE: MO) across critical financial metrics, including the dividend yield, to determine which is the best stock to buy for
Got $200? 3 Growth Stocks to Buy That Could Double Your Money
Don't let anyone tell you that you must have a boatload of money to get started investing in stocks. It's simply not true. Sure, you'll need some upfront cash. However, even a modest amount is
Why I'm Changing My Mind on AT&T Stock
AT&T (NYSE: T) has continued on a downward slide. Massive debt levels and the end of a 35-year streak of dividend increases rattled investors, and its dividend yield of 7.7% failed to stem the
Where Will Viatris Be in 5 Years?
Viatris (NASDAQ: VTRS) hasn't made for a particularly great investment since it formed nearly three years ago, through a merger of Mylan and Pfizer's Upjohn business. Down 29% since then, it has
Why Shares in Philips Soared This Week
Shares in medical technology company Koninklijke Philips (NYSE: PHG), also called Royal Philips, rose by 9.5% in the week through Friday morning. The move comes as Philips unveiled a relationship